Federal Register / Vol. 78, No. 220 / Thursday, November 14, 2013 / Notices 68449 

OS specifically requests comments on 

(1) the necessity and utility of the 

proposed information collection for the 

proper performance of the agency’s 

functions, (2) the accuracy of the 

estimated burden, (3) ways to enhance 

the quality, utility, and clarity of the 

information to be collected, and (4) the 

use of automated collection techniques 

or other forms of information 

technology to minimize the information 

collection burden. 

Darius Taylor, 

Deputy, Information Collection Clearance 

Officer. 

[FR Doc. 2013–27244 Filed 11–13–13; 8:45 am] 

BILLING CODE 4150–05–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Healthcare Research and 

Quality 

Notice of Meeting 

AGENCY: Agency for Healthcare Research 

and Quality, HHS. 

ACTION: Notice. 

SUMMARY: In accordance with section 

10(a)(2) of the Federal Advisory 

Committee Act (5 U.S.C. App. 2), 

announcement is made of an Agency for 

Healthcare Research and Quality 

(AHRQ) Special Emphasis Panel (SEP) 

meeting on ‘‘AHRQ RFA–HS14–002, 

Addressing Methodological Challenges 

in Research for Patients With Multiple 

Chronic Conditions (R21)’’. Each SEP 

meeting will commence in open session 

before closing to the public for the 

duration of the meeting. 

DATES: November 14, 2013 (Open on 

November 14 from 8:00 a.m. to 8:30 a.m. 

and closed for the remainder of the 

meeting). 

ADDRESSES: Gaithersburg Marriott 

Washingtonian Center, 9751 

Washingtonian Boulevard, Gaithersburg, 

Maryland 20878 

FOR FURTHER INFORMATION CONTACT: 

Anyone wishing to obtain a roster of 

members, agenda or minutes of the nonconfidential portions of this meeting 

should contact: Mrs. Bonnie Campbell, 

Committee Management Officer, Office 

of Extramural Research, Education and 

Priority Populations, AHRQ, 540 

Gaither Road, Room 2038, Rockville, 

Maryland 20850, Telephone: (301) 427– 

1554. 

Agenda items for this meeting are 

subject to change as priorities dictate. 

SUPPLEMENTARY INFORMATION: A Special 

Emphasis Panel is a group of experts in 

fields related to health care research 

who are invited by the Agency for 

Healthcare Research and Quality 

(AHRQ), and agree to be available, to 

conduct on an as needed basis, 

scientific reviews of applications for 

AHRQ support. Individual members of 

the Panel do not attend regularlyscheduled meetings and do not serve for 

fixed terms or a long period of time. 

Rather, they are asked to participate in 

particular review meetings which 

require their type of expertise. 

Each SEP meeting will commence in 

open session before closing to the public 

for the duration of the meeting. The SEP 

meeting referenced above will be closed 

to the public in accordance with the 

provisions set forth in 5 U.S.C. App. 2, 

section 10(d), 5 U.S.C. 552b(c)(4), and 5 

U.S.C. 552b(c)(6). Grant applications for 

the ‘‘AHRQ RFA–HS14–002, Addressing 

Methodological Challenges in Research 

for Patients With Multiple Chronic 

Conditions (R21)’’ are to be reviewed 

and discussed at this meeting. The grant 

applications and the discussions could 

disclose confidential trade secrets or 

commercial property such as patentable 

material, and personal information 

concerning individuals associated with 

the grant applications, the disclosure of 

which would constitute a clearly 

unwarranted invasion of personal 

privacy. 

Dated: November 5, 2013. 

Richard Kronick, 

AHRQ Director. 

[FR Doc. 2013–27174 Filed 11–13–13; 8:45 am] 

BILLING CODE 4160–90–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Healthcare Research and 

Quality 

Notice of Meeting 

AGENCY: Agency for Healthcare Research 

and Quality, HHS. 

ACTION: Notice. 

SUMMARY: In accordance with section 

10(a)(2) of the Federal Advisory 

Committee Act (5 U.S.C. App. 2), 

announcement is made of an Agency for 

Healthcare Research and Quality 

(AHRQ) Special Emphasis Panel (SEP) 

meeting on ‘‘AHRQ RFA–HS14–001, 

Rapid Secondary Analysis to Optimize 

Care for Patients with Multiple Chronic 

Conditions (R01)’’. Each SEP meeting 

will commence in open session before 

closing to the public for the duration of 

the meeting. 

DATES: November 13, 2013 (Open on 

November 13 from 8:00 a.m. to 8:30 a.m. 

and closed for the remainder of the 

meeting). 

ADDRESSES: Gaithersburg Marriott 

Washingtonian Center, 9751 

Washingtonian Boulevard, Gaithersburg, 

Maryland 20878. 

FOR FURTHER INFORMATION CONTACT: 

Anyone wishing to obtain a roster of 

members, agenda or minutes of the nonconfidential portions of this meeting 

should contact: Mrs. Bonnie Campbell, 

Committee Management Officer, Office 

of Extramural Research, Education and 

Priority Populations, AHRQ, 540 

Gaither Road, Room 2038, Rockville, 

Maryland 20850, Telephone: (301) 427– 

1554. 

Agenda items for this meeting are 

subject to change as priorities dictate. 

SUPPLEMENTARY INFORMATION: A Special 

Emphasis Panel is a group of experts in 

fields related to health care research 

who are invited by the Agency for 

Healthcare Research and Quality 

(AHRQ), and agree to be available, to 

conduct on an as needed basis, 

scientific reviews of applications for 

AHRQ support. Individual members of 

the Panel do not attend regularlyscheduled meetings and do not serve for 

fixed terms or a long period of time. 

Rather, they are asked to participate in 

particular review meetings which 

require their type of expertise. 

Each SEP meeting will commence in 

open session before closing to the public 

for the duration of the meeting. The SEP 

meeting referenced above will be closed 

to the public in accordance with the 

provisions set forth in 5 U.S.C. App. 2, 

section 10(d), 5 U.S.C. 552b(c)(4), and 5 

U.S.C. 552b(c)(6). Grant applications for 

the ‘‘AHRQ RFA–HS14–001, Rapid 

Secondary Analysis to Optimize Care 

for Patients with Multiple Chronic 

Conditions (R01)’’ are to be reviewed 

and discussed at this meeting. The grant 

applications and the discussions could 

disclose confidential trade secrets or 

commercial property such as patentable 

material, and personal information 

concerning individuals associated with 

the grant applications, the disclosure of 

which would constitute a clearly 

unwarranted invasion of personal 

privacy. 

Dated: November 5, 2013. 

Richard Kronick, 

AHRQ Director. 

[FR Doc. 2013–27173 Filed 11–13–13; 8:45 am] 

BILLING CODE 4160–90–P 


TKELleY on DSK3SPTVN1PROD with NOTICES